バイオティクス成分業界の世界市場、2025-2030年

ヒトミルクオリゴ糖（HMO）・ポストバイオティクスの研究と製品開発の進歩が変革的成長を促進

プロバイオティクス、プレバイオティクス、ポストバイオティクスの各分野における急速な技術革新により、バイオティクス業界は近年著しい変貌を遂げています。

プロバイオティクスの利点に対する消費者の認識、技術革新、欧州における有利な規制の進展が、このセグメントの成長を牽引しています。高繊維食の治療効果に対する消費者の意識の高まりは、プレバイオティクスの重要な成長促進要因です。2021年、International Scientific Association for Probiotics and Prebioticsはポストバイオティクスのコンセンサス定義を発表し、研究者や業界利害関係者の明確性を高めました。これにより、ポストバイオティクス分野の製品革新と市場拡大が促進されます。

プロバイオティクスとプレバイオティクスは依然としてバイオティクス成分業界の重要な構成要素ですが、ポストバイオティクス分野は、その強力な技術的パラメーターにより、また研究が進むにつれて腸と免疫の健康分野以外の可能性も明らかになりつつあることから、予測期間中に最も成長を牽引すると思われます。

用途別では、微生物に優しい機能性食品・飲料が、業界におけるプレバイオティクスの大幅な使用により、予測期間中に最も多くのバイオティクス成分を需要すると思われます。もう一つの理由は、ポストバイオティクスや有胞子性プロバイオティクスなど、メーカーによる研究の進歩と革新的なバイオティクス成分の提供です。

地理的には、予防ヘルスケアに対する消費者の意識、可処分所得の増加、急成長する経済、良好な規制環境のため、アジア太平洋地域がバイオティック原料の需要を独占しています。北米と欧州は、北米における栄養補助食品への高い消費支出と、欧州における大規模な飲食品産業により、生物学的製剤の他の主要市場となっています。

Frost & Sullivanは本レポートで5つの地域をカバーしています。北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカです。調査期間は2022年から2030年で、2024年を基準年、2025年から2030年を予測期間としています。

収益予測

基本年2022年の収益推定は58億4,610万米ドルで、2022年から2030年までの調査期間のCAGRは6.5%です。

主な競合企業

プロバイオティクス

• ADM
• Biena
• BioGaia
• Biosearch Life
• Cerbios Pharma
• Clerici-Sacco Group
• Daflon
• Danin International
• dsm-firmenich
• Gnosis by Lesaffre
• IFF
• Jiangsu Wecare Biotechnology Co., LTD.
• Kaneka Probiotic
• Lab4 Probiotic
• Lallemand
• Morinaga Milk Industry Co. Ltd.
• Natren
• Nova
• Novozymes
• NZMP
• Probi

プレバイオティクス

• Abbott Laboratories
• ADM
• Anderson Advanced Ingredients
• BASF
• Beneo GMBH
• BioNeutra
• Biosynth
• Carbiotix
• Cargill
• Clasado Biosciences
• Cosucra
• Dextra Laboratories
• dsm-firmenich
• Elicylt S.A
• Fonterra (NZMP)
• FrieslandCampina Ingredients
• Fuji Nihon Seito Corporation
• Galam
• GeneChem
• Gnubiotic Sciences S.A
• Grain Processing Corporation
• IFF

ポストバイオティクス

• ADM
• Asahi Group
• Bereum
• dsm-firmenich
• Glac Biotech Co Ltd
• Humana Spain S.L.
• IDLONG Bioscience Co. Ltd
• Kerry
• Kyowa Hakko (Kirin Holdings Co., Ltd.)
• Morinaga Milk Industry Co. Ltd.
• Novozymes
• Sabinsa
• Synformulas
• SynBalance

目次

成長環境：バイオティクス成分業界のトランスフォーメーション

• なぜ成長が難しくなっているのか？
• The Strategic Imperative 8
• バイオティクス成分業界に対する戦略的インペラティブトップ3の影響

バイオティクス成分業界におけるエコシステム

• マイクロバイオームとは何か？
• ヒトの健康におけるマイクロバイオームの役割
• 腸内マイクロバイオーム業界のエコシステム
• 分析の範囲
• 成分別のセグメンテーション
• 市場の定義：バイオティクス成分
• 市場の定義：プロバイオティクス成分
• 市場の定義：プレバイオティクス成分
• 市場の定義：ポストバイオティクス成分
• アプリケーションの定義

バリューチェーン

競合環境

主な競合企業

• 競合ベンチマーキング：プロバイオティクス成分
• 競合ベンチマーキング：プレバイオティクス成分
• 競合ベンチマーキング：ポストバイオティクス成分
• プロバイオティクス成分：主要メーカーの市場活動、2022-2024年
• プレバイオティクス成分：主要メーカーの市場活動、2022-2023年
• プレバイオティクス成分：主要メーカーの市場活動、2022-2024年
• ポストバイオティクス成分：主要メーカーの市場活動、2023-2024年

バイオティクス成分業界の成長要因

• 成長指標
• 促進要因
• 促進要因分析
• 成長抑制要因
• 成長抑制分析
• 合成バイオ業界のスポットライト
• 市場動向
• 予測考察
• 収益予測
• 製品カテゴリー別の収益予測
• 地域別の収益予測
• アジア太平洋の国別の収益予測
• 価格分析と予測の前提条件
• 競合情勢

成長ジェネレーター：プロバイオティクス成分

• 成長指標
• プロバイオティクスの紹介
• プロバイオティクスのバリューチェーン
• 収益予測
• 収益予測分析
• 成分別の収益予測
• 成分別の収益予測分析
• 用途別の収益予測
• 用途別の収益予測分析
• ヘルスベネフィット別の収益予測
• ヘルスベネフィット別の収益予測分析
• 地域別の収益予測
• アジア太平洋の国別の収益予測
• 地域別の収益予測分析

成長ジェネレーター：プレバイオティクス成分

• 成長指標
• プレバイオティクスの紹介
• 食物繊維 vs. プレバイオティクスの理解
• プレバイオティクスのバリューチェーン
• 収益予測
• 収益予測分析
• 成分別の収益予測
• 成分別の収益予測分析
• 用途別の収益予測
• 用途別の収益予測分析
• ヘルスベネフィット別の収益予測
• ヘルスベネフィット別の収益予測分析
• 地域別の収益予測
• アジア太平洋の国別の収益予測
• 地域別の収益予測分析

成長ジェネレーター：ポストバイオティクス成分

• ポストバイオティクスの紹介
• ポストバイオティクスのバリューチェーン
• 成長指標
• 収益予測
• 収益予測分析
• 用途別の収益予測
• 用途別の収益予測分析
• 成分別の収益予測
• ヘルスベネフィット別の収益予測
• 成分・ヘルスベネフィット別の収益予測分析
• 地域別の収益予測
• アジア太平洋の国別の収益予測
• 地域別の収益予測分析

バイオティクス成分業界における成長機会ユニバース

• 成長機会1：成長製品カテゴリーとしてのポストバイオティクス
• 成長機会2：プレバイオティクス分野における製品イノベーション
• 成長機会3：幅広い治療分野への進出

付録・次のステップ

• 成長機会のメリットと影響
• 次のステップ
• 添付リスト
• 免責事項

Research and Product Development Advances in Human Milk Oligosaccharides and Postbiotics are Driving Transformational Growth

The biotics industry has witnessed a remarkable transformation in recent years, driven by rapid innovations in each biotics segment: probiotics, prebiotics, and postbiotics.

Consumer awareness of probiotic benefits, innovations, and favorable regulatory developments in Europe drive the segment's growth. Increasing consumer awareness of the therapeutic benefits of a high-fiber diet is a crucial growth propeller for prebiotics. In 2021, the International Scientific Association for Probiotics and Prebiotics published the consensus definition of postbiotics, which enhanced clarity for researchers and industry stakeholders. This drives product innovation and market expansion in the postbiotics space.

While probiotics and prebiotics remain vital components of the biotic ingredients industry, the postbiotics segment will likely drive the most growth during the forecast period due to its strong technical parameters and as research continues to unveil their potential beyond gut and immune health areas.

By application, microbiome-friendly functional food and beverages will demand the most biotic ingredients during the forecast period due to the substantial use of prebiotics in the industry. Another reason is advancements in research and innovative biotic ingredient offerings by manufacturers, such as postbiotics and spore-forming probiotics.

Geographically, Asia-Pacific dominates the demand for biotic ingredients because of consumer awareness of preventive healthcare, increasing disposable income, fast-growing economies, and favorable regulatory environment. North America and Europe are the other major markets for biotic ingredients due to high consumer spending on dietary supplements in North America and the massive food and beverage industry in Europe.

Frost & Sullivan covers 5 regions in this report: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The study period is 2022 to 2030, with 2024 as the base year and 2025 to 2030 as the forecast period.

Revenue Forecast

The revenue estimate for the base year 2022 is $5,846.1 million with a CAGR of 6.5% for the study period from 2022 to 2030.

The Impact of the Top 3 Strategic Imperatives on the Biotic Ingredients Industry

Geopolitical Chaos

WHY

• Despite inflationary pressures, the demand for biotic ingredients remained strong from 2022 to 2024.
• For example, Chr. Hansen (now Novozymes), a probiotics market leader, reported a 17% organic sales growth in health and nutrition sector in 2022. This indicates a rebound in consumer interest in probiotic supplements following the COVID-19 pandemic.
• Similarly, leading prebiotics manufacturer Beneo found that consumers prioritize product efficacy and proven health claims over price when choosing prebiotic products, even amid rising living expenses.

FROST PERSPECTIVE

• Companies in this market will need to remain wary of inflationary pressure by offering reliable and science-backed claims to sustain premium positioning even in challenging financial times.

Disruptive Technologies

WHY

• The biotics industry still faces formulation challenges in the more established product categories of viable and non-spore-forming probiotics. Currently, the most compelling innovations in the industry that can combat these challenges are prebiotics and spore-forming probiotics.
• Prebiotics manufacturers focus on reducing dosage requirements to develop more novel formats; for instance, OptiBiotix offers Opti005, and FrieslandCampina offers Biotis(R) GOS-OP High Purity. Both ingredients can significantly increase the beneficial gut microbial load at low dosages.

FROST PERSPECTIVE

• Disruptive new technologies can overcome the challenges associated with established biotics industry products. However, research is necessary to scientifically back claims of health benefits. Ingredient manufacturers should continue prioritizing R&D to support product innovations and formulations.

Transformative Megatrends

WHY

• Several megatrends are having a transformative impact on the biotics industry. Artificial intelligence (AI) is transforming all industries, and this is no different. The human microbiome is incredibly complex, and the use of AI-driven systems to identify, characterize, and research microbial strains is likely to gain momentum in the probiotics and postbiotics space.
• Personalization is a rapidly growing trend in the nutrition industry. Personalization technology is gaining momentum in the biotics industry, with microbiome testing kits, tailored probiotics, and AI-assisted programs offering consumers customized solutions.

FROST PERSPECTIVE

• All these megatrends can potentially disrupt existing market participants and present significant opportunities for growth.
• To stay competitive and meet the demand for innovative and effective solutions, options available to companies include investing in technology advancements, using data for personalized products, and developing new services.

Scope of Analysis

• The research scope includes biotic ingredients like probiotics, prebiotics, and postbiotics that help maintain a healthy human microbiome and prevent the growth of pathogenic microorganisms.
• The study's geographic scope is global and includes the following regions:
• North America: The United States and Canada
• Europe: European Economic Area and European Trade Association states, including the United Kingdom
• Asia-Pacific (APAC): China, Japan, South Korea, Australia, New Zealand, Association of Southeast Asian Nations (Indonesia, Thailand, Singapore, Malaysia, and the Philippines), and South Asian countries (India, Pakistan, Bangladesh, Sri Lanka, and Nepal); country-level segmentation for Asia-Pacific is included in the research scope for each biotic ingredient
• Latin America (LATAM): All LATAM countries, including Mexico
• Middle East and Africa (MEA): Africa and all Middle Eastern countries, including Turkey

The study analyzes each biotic ingredient type with respect to application, health benefits, and region. The scope and segmentation of application and health benefits vary for each type of biotic ingredient, depending on its market landscape.

Probiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, medical food, and pharmaceuticals

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, beauty-from-within, sports nutrition, women's health (vaginal and urinary health, reproductive health), bone and joint health, and others (oral and eye health)

Prebiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, and medical food

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, beauty-from-within, sports nutrition, women's health (vaginal and urinary health, reproductive health), and bone and joint health

Postbiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, and pharmaceuticals

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, and others (women's health, eye health, and beauty-from-within)

Key Competitors

Probiotics

• ADM
• Biena
• BioGaia
• Biosearch Life
• Cerbios Pharma
• Clerici-Sacco Group
• Daflon
• Danin International
• dsm-firmenich
• Gnosis by Lesaffre
• IFF
• Jiangsu Wecare Biotechnology Co., LTD.
• Kaneka Probiotic
• Lab4 Probiotic
• Lallemand
• Morinaga Milk Industry Co. Ltd.
• Natren
• Nova
• Novozymes
• NZMP
• Probi

Prebiotics

• Abbott Laboratories
• ADM
• Anderson Advanced Ingredients
• BASF
• Beneo GMBH
• BioNeutra
• Biosynth
• Carbiotix
• Cargill
• Clasado Biosciences
• Cosucra
• Dextra Laboratories
• dsm-firmenich
• Elicylt S.A
• Fonterra (NZMP)
• FrieslandCampina Ingredients
• Fuji Nihon Seito Corporation
• Galam
• GeneChem
• Gnubiotic Sciences S.A
• Grain Processing Corporation
• IFF

Postbiotics

• ADM
• Asahi Group
• Bereum
• dsm-firmenich
• Glac Biotech Co Ltd
• Humana Spain S.L.
• IDLONG Bioscience Co. Ltd
• Kerry
• Kyowa Hakko (Kirin Holdings Co., Ltd.)
• Morinaga Milk Industry Co. Ltd.
• Novozymes
• Sabinsa
• Synformulas
• SynBalance

Growth Drivers

Research innovations drive the evolution of the gut microbiome industry.

Rising consumer awareness about probiotic benefits, innovations, and favorable regulatory developments in Europe drive the market growth of probiotics.

Increasing awareness of a high-fiber diet linked to therapeutic benefits among consumers is a key growth propeller for prebiotics.

ISAPP's publication of the consensus definition of postbiotics enhanced clarity for researchers and industry stakeholders, driving product innovation and market expansion.

Changes in government policies in China boost demand for biotic ingredients.

Growth Restraint

Biotic Ingredients: Growth Restraints, Global, 2025-2030

• The declining birth rate globally and frequent infant formula recalls in the United States impact the growth of the infant nutrition industry and the demand for biotic ingredients.
• The lack of harmonized regulation for biotic ingredients in EU countries hinders market growth in the region.
• Lack of clear understanding and knowledge about biotic ingredients globally is restricting market growth.

Table of Contents

Growth Environment: Transformation in the Biotic Ingredients Industry

• Why Is It Increasingly Difficult to Grow?
• The Strategic Imperative 8
• The Impact of the Top 3 Strategic Imperatives on the Biotic Ingredients Industry

Ecosystem in the Biotic Ingredients Industry

• What is the Microbiome?
• Role of Microbiome in Human Health
• Ecosystem of the Gut Microbiome Industry
• Scope of Analysis
• Segmentation by Ingredients
• Market Definitions: Biotic Ingredients
• Market Definitions: Probiotic Ingredients
• Market Definitions: Prebiotic Ingredients
• Market Definitions: Postbiotic Ingredients
• Application Definitions

Value Chain

Competitive Environment

Key Competitors

• Competitive Benchmarking: Probiotic Ingredients
• Competitive Benchmarking: Prebiotic Ingredients
• Competitive Benchmarking: Postbiotic Ingredients
• Probiotic Ingredients: Market Activities of Leading Manufacturers 2022-2024
• Prebiotic Ingredients: Market Activities of Leading Manufacturers 2022-2023
• Prebiotic Ingredients: Market Activities of Leading Manufacturers 2022-2024
• Postbiotic Ingredients: Market Activities of Leading Manufacturers 2023-2024

Growth Generator in the Biotic Ingredients Industry

• Growth Metrics
• Growth Drivers
• Growth Driver Analysis
• Growth Restraint
• Growth Restraint Analysis
• Spotlight on the Synbiotics Industry
• Market Trends
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast by Product Category
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Pricing Analysis and Forecast Assumptions
• Competitive Landscape

Growth Generator: Probiotic Ingredients

• Growth Metrics
• Introduction to Probiotics
• Probiotics Value Chain
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Ingredient
• Revenue Forecast Analysis by Ingredient
• Revenue Forecast by Application
• Revenue Forecast Analysis by Application
• Revenue Forecast by Health Benefit
• Revenue Forecast Analysis by Health Benefit
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Revenue Forecast Analysis by Region

Growth Generator: Prebiotic Ingredients

• Growth Metrics
• Introduction to Prebiotics
• Understanding Dietary Fibers Vs Prebiotics
• Prebiotics Value Chain
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Ingredient
• Revenue Forecast Analysis by Ingredient
• Revenue Forecast by Application
• Revenue Forecast Analysis by Application
• Revenue Forecast by Health Benefit
• Revenue Forecast Analysis by Health Benefit
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Revenue Forecast Analysis by Region

Growth Generator: Postbiotic Ingredients

• Introduction to Postbiotics
• Postbiotics Value Chain
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Application
• Revenue Forecast Analysis by Application
• Revenue Forecast by Ingredient
• Revenue Forecast by Health Benefit
• Revenue Forecast Analysis by Ingredient and Health Benefit
• Revenue Forecast by Region
• Revenue Forecast by Asia-Pacific Country
• Revenue Forecast Analysis by Region

Growth Opportunity Universe in the Biotic Ingredients Industry

• Growth Opportunity 1: Postbiotics as a Growth Product Category
• Growth Opportunity 2: Product Innovations in the Prebiotics Space
• Growth Opportunity 3: Expansion into a Wider Range of Therapeutic Areas

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer